Deleuze V, Stephen T, Salma M, Orfeo C, Jorna R, Maas A
Sci Rep. 2025; 15(1):8996.
PMID: 40089598
DOI: 10.1038/s41598-025-94222-8.
Wonkam A, Esoh K, Levine R, Ngo Bitoungui V, Mnika K, Nimmagadda N
Nat Commun. 2025; 16(1):2092.
PMID: 40025045
PMC: 11873275.
DOI: 10.1038/s41467-025-57413-5.
Huang L, Zhang Q, Ye Y, Long Y, Huang H, Niu C
Ann Hematol. 2025; .
PMID: 40016399
DOI: 10.1007/s00277-025-06277-2.
Ropero P, Peral M, Sanchez-Martinez L, Rochas S, Gomez-Alvarez M, Nieto J
Front Med (Lausanne). 2025; 12:1347026.
PMID: 40012971
PMC: 11864215.
DOI: 10.3389/fmed.2025.1347026.
Zhang H, Zeng J, Zhang F, Liu J, Liang L
Biology (Basel). 2025; 14(1).
PMID: 39857257
PMC: 11759832.
DOI: 10.3390/biology14010026.
Hotspots and status of Fetal Alpha-Thalassemia from 2009 to 2023: a bibliometric analysis.
Li Q, Li X, He S, Li J
Front Pediatr. 2024; 12:1467760.
PMID: 39726529
PMC: 11670076.
DOI: 10.3389/fped.2024.1467760.
Genetic Polymorphisms Associated with Fetal Hemoglobin (HbF) Levels and F-Cell Numbers: A Systematic Review of Genome-Wide Association Studies.
Stephanou C, Menzel S, Philipsen S, Kountouris P
Int J Mol Sci. 2024; 25(21).
PMID: 39518961
PMC: 11546522.
DOI: 10.3390/ijms252111408.
Structural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6.
Viennet T, Yin M, Jayaraj A, Kim W, Sun Z, Fujiwara Y
Structure. 2024; 32(12):2276-2286.e4.
PMID: 39423807
PMC: 11625000.
DOI: 10.1016/j.str.2024.09.022.
TR4 and BCL11A repress γ-globin transcription via independent mechanisms.
Wang Y, Myers G, Yu L, Deng K, Balbin-Cuesta G, Singh S
Blood. 2024; 144(26):2762-2772.
PMID: 39393056
PMC: 11862819.
DOI: 10.1182/blood.2024024599.
Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease.
Igbineweka N, van Loon J
NPJ Genom Med. 2024; 9(1):44.
PMID: 39349487
PMC: 11442622.
DOI: 10.1038/s41525-024-00427-7.
Toward life without sickle cell disease.
Dave U, Bungert J
Mol Ther. 2024; 32(10):3197-3198.
PMID: 39293432
PMC: 11489554.
DOI: 10.1016/j.ymthe.2024.09.004.
Transcriptional Repressor BCL11A in Erythroid Cells.
Zheng G, Orkin S
Adv Exp Med Biol. 2024; 1459:199-215.
PMID: 39017845
DOI: 10.1007/978-3-031-62731-6_9.
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell disease.
Hart K, Liu B, Brown D, Campo-Fernandez B, Tam K, Orr K
Mol Ther Methods Clin Dev. 2024; 32(2):101254.
PMID: 38745893
PMC: 11091523.
DOI: 10.1016/j.omtm.2024.101254.
Detection of Asymptomatic Sickle Cell Hemoglobin Carriers and Fetal Hemoglobin Regulating Genetic Variants in African Descendants from Oaxaca, Mexico.
de Los Angeles Romero-Tlalolini M, Aguilar-Ruiz S, Baltierrez-Hoyos R, Vargas-Arzola J, Hernandez-Osorio L, Vasquez-Garzon V
Anemia. 2024; 2024:4940760.
PMID: 38716363
PMC: 11074717.
DOI: 10.1155/2024/4940760.
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Ojewunmi O, Adeyemo T, Oyetunji A, Inyang B, Akinrindoye A, Mkumbe B
Hum Mol Genet. 2024; 33(10):919-929.
PMID: 38339995
PMC: 11070134.
DOI: 10.1093/hmg/ddae014.
Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
Parekh D, Eaton W, Thein S
Blood. 2023; 143(10):866-871.
PMID: 38118071
PMC: 10940061.
DOI: 10.1182/blood.2023021167.
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham J, Estepp J, Weiss M, Rashkin S
JAMA Netw Open. 2023; 6(10):e2337484.
PMID: 37851445
PMC: 10585422.
DOI: 10.1001/jamanetworkopen.2023.37484.
miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
Simbula M, Manchinu M, Mingoia M, Pala M, Asunis I, Caria C
Mol Ther Nucleic Acids. 2023; 34:102025.
PMID: 37744176
PMC: 10514143.
DOI: 10.1016/j.omtn.2023.09.002.
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Piel F, Rees D, DeBaun M, Nnodu O, Ranque B, Thompson A
Lancet Haematol. 2023; 10(8):e633-e686.
PMID: 37451304
PMC: 11459696.
DOI: 10.1016/S2352-3026(23)00096-0.
MBD2a-NuRD binds to the methylated γ-globin gene promoter and uniquely forms a complex required for silencing of HbF expression.
Shang S, Li X, Azzo A, Truong T, Dozmorov M, Lyons C
Proc Natl Acad Sci U S A. 2023; 120(25):e2302254120.
PMID: 37307480
PMC: 10288633.
DOI: 10.1073/pnas.2302254120.